The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Regorafenib in older adults with metastatic colorectal cancer: A multi-center, single arm phase II trial.
 
Nabeel Badri
Research Funding - Pharmaxis (Inst)
 
Jason Zittel
No Relationships to Disclose
 
Andrea M. Baran
No Relationships to Disclose
 
Efrat Dotan
Honoraria - Pfizer
Consulting or Advisory Role - G1 Therapeutics; Helsinn Therapeutics; Incyte; Taiho Pharmaceutical
Research Funding - Gilead Sciences (Inst); Incyte (Inst); Ipsen (Inst); Kinnate Biopharma (Inst); Lilly (Inst); Lutris (Inst); NGM Biopharmaceuticals (Inst); Relay Therapeutics (Inst); Theradex (Inst); Zymeworks (Inst)
 
Joleen M. Hubbard
Consulting or Advisory Role - Bayer (Inst); BeiGene (Inst); Incyte (Inst); Incyte (Inst); Merck; Taiho Oncology (Inst)
Research Funding - Bayer (Inst); G1 Therapeutics (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Pionyr (Inst); Seagen (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst); Translational Research in Oncology (Inst); Treos Bio (Inst); Trovagene (Inst)
 
Marcus Smith Noel
Consulting or Advisory Role - Celgene; Ipsen; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Daiichi Sankyo/Astra Zeneca; Taiho Pharmaceutical
Research Funding - ERYTECH Pharma
 
Aram F Hezel
No Relationships to Disclose
 
Mohamedtaki Abdulaziz Tejani
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Natera
Research Funding - Bayer (Inst)
 
Supriya Gupta Mohile
No Relationships to Disclose